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Abstract
Background: Mosaicism for copy number and copy neutral chromosomal rearrangements has been recently
identified as a relatively common source of genetic variation in the normal population. However its prevalence is
poorly defined since it has been only studied systematically in one large-scale study and by using non optimal ad-
hoc SNP array data analysis tools, uncovering rather large alterations (> 1 Mb) and affecting a high proportion of
cells. Here we propose a novel methodology, Mosaic Alteration Detection-MAD, by providing a software tool that
is effective for capturing previously described alterations as wells as new variants that are smaller in size and/or
affecting a low percentage of cells.
Results: The developed method identified all previously known mosaic abnormalities reported in SNP array data
obtained from controls, bladder cancer and HapMap individuals. In addition MAD tool was able to detect new
mosaic variants not reported before that were smaller in size and with lower percentage of cells affected. The
performance of the tool was analysed by studying simulated data for different scenarios. Our method showed high
sensitivity and specificity for all assessed scenarios.
Conclusions: The tool presented here has the ability to identify mosaic abnormalities with high sensitivity and
specificity. Our results confirm the lack of sensitivity of former methods by identifying new mosaic variants not
reported in previously utilised datasets. Our work suggests that the prevalence of mosaic alterations could be
higher than initially thought. The use of appropriate SNP array data analysis methods would help in defining the
human genome mosaic map.
Background
Microarray platforms based on Single Nucleotide Poly-
morphisms (SNP arrays) are powerful tools in the
research of genomic structural variation because they
allow the integration of genotype and copy-number
information. Researchers can simultaneously identify
both copy number and copy number neutral changes,
using the log2-ratio (LRR) intensity signal and the allele
genotyping of the probes [1-6]. While SNP arrays have
been effectively used in the study of copy number varia-
tion (CNV) and single nucleotide polymorphism (SNP)
g e n o t y p i n g ,o n l yr e c e n t l yt h e yh a v eb e e nu t i l i s e dt o
identify the mosaic occurrence of copy number and
copy neutral genomic abnormalities [7]. Genetic mosai-
cism is recognized as the presence of two or more dif-
ferent cell populations with different genotypes in one
single individual, developed from a single fertilized egg.
Such genetic abnormalities may result from a mutation
during development that is propagated to only a subset
of the adult cells. Somatic mosaicism for chromosomal
rearrangements has been recently described on the basis
of comparative analysis of differentiated human tissues
from adult individuals [8] and divergence between iden-
tical twins [9]. Moreover it is well known that some
mosaic abnormalities are involved in multiple develop-
mental and tissue-specific disorders [10-16]. Despite of
all these evidences, the frequency and extent of chromo-
somal mosaicism in adult normal population has been
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real contribution to intra- and inter-individual genome
variation is yet to be determined. For helping in that
purpose, specialized algorithms and data analysis tools
aimed at calling the mosaic occurrence of structural var-
iation are badly needed.
Mosaic events can be captured by analysing SNP array
data, specially from assessing multiple clusters of hetero-
zygous alleles showing B allele frequency (BAF) and LRR
values different from the those expected for regular het-
erozygous deletions, duplications or loss of heterozygosis
events (See Additional File 1 - Figure S1 for examples of
different types of mosaic rearrangements). Two recent
studies have demonstrated that structural variants
occurring in mosaicism are more frequent than
expected, and thus they may play a relevant role in
human diversity and disease susceptibility [7,17]. While
both studies used Illumina SNP array data, only Rodrí-
guez-Santiago et al. (2010) used tools for discovering
occurrences in a systematic way. Their approach may,
however, result in the underestimation of mosaic preva-
lence in two challenging situations: 1) small rearrange-
ments and 2) rearrangements affecting a low percentage
of cells. In addition, the used algorithm was computa-
tionally demanding (2 weeks to analyze about 2,000
individuals genotyped with Illumina HumanHap 1M),
which constitutes a technical drawback in the analysis of
high-density arrays of thousands of individuals.
Mosaicism detection can be cast as a segmentation
problem [18]. In fact BAFsegmentation is a software
developed for the identification of mosaicism in cancer
cells based on the circular binary segmentation (CSB)
algorithm [19]. The disadvantage of this procedure is
the lack of a method to clearly control the false discov-
ery rate (FDR) [20].
As an alternative segmentation method, the genome
alteration detection analysis (GADA) can also identify
allelic imbalances by using BAF values provided by SNP
arrays [21]. This value is the fraction of the total signal
d u et oas p e c i f i ca l l e l ea n di ti st h es u i t e dv a l u et os t u d y
allelic imbalances underlying mosaicism for genomic
rearrangements. Compared to circular binary segmenta-
tion (CBS) [19], GADA has similar accuracy, and is sev-
eral orders of magnitude faster. Recently, GADA
segmentation was applied to CNV calling by using LRR
values from SNP array data in very large data sets with
high efficiency and accuracy [6,22]. To overcome the spe-
cific difficulties in the identification of mosaic events
from SNP arrays, we have developed Mosaic Alteration
Detection-MAD method which includes both statistic
(including FDR control) and bioinformatic tools to speci-
fically analyse BAF values from SNP array data. The soft-
ware presented here improves SNP array data analysis
allowing the capture of mosaic copy number (deletions,
duplications, aneuploidies) and copy neutral changes
(uniparental disomies, UPD, namely the occurrence of
two copies of a particular chromosome from the same
parent), as well as regions of homozygosity due to iden-
tity-by-descent. The developed method was used to ana-
lyse Illumina HumanHap 1M SNP array data obtained
from control, bladder cancer and HapMap individuals.
We also compared its performance (sensitivity and speci-
ficity) with BAFsegmentation [18] under several simu-
lated challenging scenarios like small altered regions, low
percentage of mosaic cells and poor array quality. Finally,
our tool was applied to SNP array data previously utilised
for detecting mosaic abnormalities [17,18]. While all pub-
lished findings were successfully identified, additional
mosaic events were detected by MAD and experimentally
validated afterwards. Our results suggest that improved
methods can accurately capture mosaic chromosomal
rearrangements using SNP array data and that their pre-
valence is higher than initially thought.
Results and Discussion
Method development
Figure 1 contains a scheme showing the overall perfor-
mance of the MAD algorithm, using CASE571 carrying
a mosaic deletion in chromosome 20 from Mb 31 to 48,
as an example. The distribution of LRR and BAF values
for the individual can be visualised in Figure 1a. Two
clusters of BAF values (in red) are clearly visible
between MB 31 to 48 that would be absent in a stan-
dard heterozygous deletion. Therefore, the abnormality
could be detected by the deviation of the BAF signal
from the expected values typical for non-altered homo-
zygous (1 or 0) or non-altered heterozygous probes
(0.5). The difference between observed and expected
BAF is denoted as b-deviation. Altered regions can be
called by detecting segments with b-deviation values dif-
ferent from zero using algorithms such as GADA and
CBS. Segmentation methods usually assume that the
data are normally distributed. However this is not the
case for b-deviation as Figure 1b demonstrates. The
further variable F
-1 (Figure 1c), which is a probit trans-
formation on b-deviation having a normal distribution,
can be applied to perform the segmentation procedure
(Figure 1d) controlling the FDR parameter. Once the
segments have been called by assessing BAF values as
described above, the average LRR of the called segment
is calculated to help in determining whether the
abnormality is affecting the copy number (Figure 1e).
New mosaic rearrangements from previously utilised SNP
array datasets
HapMap individuals
To check how the algorithm works with real data MAD
tool was applied to data obtained from lymphoblastic
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Page 2 of 11cell line DNA of 125 individuals from HapMap popula-
tion (60 CEU, 60 YRI and 5 replicates) hybridized with
Illumina HumanHap 1M SNP array, available at public
repositories http://www.hapmap.org. For MAD, para-
meters were set to T =8 ,a = 0.8 (see Method section
for a definition of these two parameters and Additional
File 2 for a table including the recommended settings
for being used in a preliminary scan) and the minimum
probe length for detection at MinSegLen = 300,
meaning the algorithm is able to detect altered regions
> 0.9 Mb for 1 Mb arrays. Furthermore, with a =0 . 8
finding few number of segments for each individual is
expected. With these parameters, the FDR was < 0.0001.
The tool identified 9 mosaic rearrangements in 8 indivi-
duals (Table 1). Mosaic uniparental disomy was
observed for chromosome 2 in one individual
(NA18855). Mosaic duplications were detected in three
individuals affecting chromosome 2 (NA10857), chro-
mosome 19 (NA11882) and chromosome 8 (NA18972).
Gains of the entire chromosome compatible with mosaic
trisomies were observed in 4 individuals (NA11236,
NA12248, NA12875 and NA19193) involving chromo-
somes 15, 9 and 14, 2 and 12, respectively and different
percentage of mosaic cells (see Additional File 3). In
addition the performance of MAD was compared to
BAFsegmentation using default parameters in the Hap-
Map individuals analysed. Compared to MAD, BAFseg-
mentation algorithm was unable to detect 2 alterations,
trisomies with very low proportion of affected cells (see
Figure 2 for one case). The obtained results are consis-
tent with the simulation analysis performed in the pre-
sent work where BAFsegmentation showed less
sensitivity for low mosaic cell proportions (see section
below).
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Figure 1 Algorithm process to detect genomic imbalances using SNP array data. (a) B allele frequency (BAF, red dots) from heterozygous
clusters different to non altered probes (BAF 0.5) can be used to iddentify genomic imbalances. (b) b-deviation, bdev, is computed to detect
altered regions. (c) Probit transformation, F
-1(bdev), is used to achieve normallity before applying a segmentation algorithm. (d) Segmentation
algorithm detects altered regions. False discovery rate (FDR) can be controlled in this step. (e) After calling segments by using BAF values, LRR
allows to classify altered regions in different kind of mosaic structural variations.
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Page 3 of 11Control and bladder cancer individuals
The tool was also used to re-analyse previously defined
and validated mosaic rearrangements reported elsewhere
[17]. A selected subset of 31 mosaic rearrangements
among 58 samples was initially studied. Parameters were
set to T =8 ,a =0 . 8a n dMinSegLen = 1500 that are
predicted to have a FDR of 0.0001.
Using these settings the tool was able to detect all pre-
viously defined mosaic rearrangements but one (30/31).
Remarkably, the algorithm did not provide any false-
positive calls. The false-negative result was a small dele-
tion on chromosome 20 only comprised by 248 probes
(that is not possible to be detected with MinSegLen =
1500). Nonetheless, this alteration was detected by
Table 1 Summary of mosaic structural variants identified in HapMap individuals by using MAD tool.
Sample BAFsegmentation? Chr Event Start End Size (Mb)
NA10857 Yes 2 Duplication 59,505,990 60,622,482 1.1
NA11882 Yes 19 Duplication 57,313,456 63,802,440 6.7
NA12236 Yes 15 Trisomy pter qter
NA12248 No 14 Trisomy pter qter
NA12248 No 9 Trisomy pter qter
NA12875 Yes 2 Trisomy pter qter
NA18855 Yes 2 UPD pter 94,755,295 94,7
NA18972 Yes 8 Duplication 4,669,277 5,914,260 1.2
NA19193 Yes 12 Trisomy pter qter
The second column indicates whether BAFsegmentation algorithms also found the alteration.
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Figure 2 Example of mosaic rearrangement detected in HapMap individuals. The plot shows a trisomy in chromosome 14 for the
individual NA12248 detected using MAD (not detected using BAFsegmentation). The same alteration was also identified when analysing a
replicated experiment of the same HapMap individual. Red dots represent B-allele frequency (BAF), while black dots show log2ratio (LRR) values.
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Page 4 of 11changing MinSegLen to 200, and no other abnormal-
ity was found in this sample by using this setting. Over-
all, the predicted FDR using MinSegLen = 200 is
0.001. The MinSegLen is a parameter that can be
adjusted depending on probe coverage of the array, and
it can be reduced for hihg-density arrays such as Illu-
mina HumanHap 1M. The complete dataset of 1991
samples was studied afterwards [17]. We set MinSe-
gLen = 100 and T = 8, to increase power detection at
the expense of higher FDR (0.05). The algorithm
detected 7 new segments not identified either with pre-
vious tools or with BAFsegmentation (Table 1 and
Additional File 1 - Figures S5 to S11). These abnormal-
ities were smaller in size than those previously reported,
with the minimum size of ~ 500 Kb (See Additional File
1 - Figure S5 for an example) which represents an
improvement in the detection of smaller events. We
experimentally validated the mosaic abnormalities in all
6 available DNA samples by multiple ligase-dependent
probe amplification (MLPA) (Table 2 and Additional
File 1 - Figures S12 to S17). The algorithm also detected
98 duplication segments ranging in size from ~ 0.2 to ~
4 Mb with average LRR < 0.15 suggestive of possibly
being mosaics (Additional File 4).
Simulation Studies
Several simulation studies were run to further assess the
performance of MAD and BAFsegmentation analysis
tools. Specifically, eight scenarios were considered
depending on i) the percentage of affected cells with the
altered region: 10% and 20%; ii) the length of the altera-
tion: small and large; and iii) the quality of data: good
and noisy. The BAF value was simulated for 20,000
SNPs using a log-normal distribution with mean 0 for
AA homozygous and mean 1 for BB homozygous
probes. A normal distribution with mean 0.5 was used
to generate heterozygous markers. Different quality data
was generated varying the variance of these distributions
(0.03 for good quality and 0.1 for noisy). The percentage
of cells with an abnormal region was simulated by
changing the mean value for heterozygous probes (0.55
and 0.60 for 10% and 20% of affected cells, respectively).
Finally, abnormal large regions were generated by modi-
fying 10,000 markers, while small aberrant regions con-
tained 1,000 probes. These simulations allowed the
calculation of: 1) the ROC curve (True-positive Vs False
positive rates); 2) the FDR; and 3) differences in sensitiv-
ities of MAD and BAFsegmentation. The results were
based on 1,000 simulations.
True-positive (TPR) and False-positive (FPR) rates
The performance of MAD algorithm was examined
under changes in the parameters, a Î {0.2, 0.8} and T Î
{2.5, 3, 3.5, 4, 4.5, 5}, that control its sensitivity and spe-
cificity. Figure 3 shows the ROC curve (e.g. TPR vs
FPR) for different simulated scenarios and for the case
of having moderate to large altered regions. As
expected, the TPR improves when both quality data and
percentage of affected cells increase. The performance
w a sa l m o s tp e r f e c t( e . g .a r e au n d e rt h eR O Cc u r v ei s
near 1) when quality data was good and the degree of
mosaicism was at least 20% (continuous red line). Simi-
lar results were obtained when analyzing simulated seg-
ments with less density (1,000 abnormal SNPs -
Additional File 1 - Figure S4).
False discovery rate (FDR)
As a significant feature MAD incorporates a general
method to control FDR. This method was validated by
using simulated datasets and comparing estimated with
expected FDR values. Figure 4 shows the FDR compari-
son for different scenarios under a = 0.8. A good agree-
ment between simulated and estimated FDR in all
situations was observed: the FDR decreased when either
T , the percentage of affected cells or data quality
increased. Similar results were obtained for a =0 . 2 ,
where the FDR is larger than the previous case, as
expected.
Comparison with BAFsegmentation
The performance of MAD and BAFsegmentation tools
was studied by simulating low cell proportion of mosaic
alterations. A single segment of 1000 probes within a
Table 2 Eight new mosaic events identified in SNP array data from individuals previously analysed in Rodriguez-
Santiago et al. (2010).
Sample Chr Event Start End Size (Mb) MLPA validation
1
CONTROL870 2 Deletion 25,056,172 25,570,101 513,929 Yes
CONTROL1210 2 Deletion 25,312,050 26,013,444 701,394 Yes
CASE623 4 Duplication 158,590,621 159,723,224 1,132,603 Yes
CASE741 6 Duplication 162,534,963 163,052,519 517,556 NA
CASE526 7 Deletion 138,459,817 139,610,819 1,151,002 Yes
CASE508 11 Duplication 122,663,431 123,143,910 488,481 Yes
CONTROL413 15 Duplication 48,349,855 48,838,336 517,556 Yes
The new abnormalities observed were smaller than those previously reported. Figures are available in the Additional File 6 - Figures S5 to S11.
1 Additional File 5 (Section 4) shows the MLPA electropherograms and control comparisons.
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Page 5 of 11DNA chunk of 20-Kb in length was simulated 200 times
for different proportion of mosaic cells (0, 0.01, ... 0.15).
Parameters of both algorithms were fixed such as opti-
mum specificity was achieved for both methods across
the whole range. In other words, the algorithms were
adjusted for not finding any segment which was comple-
tely disjointed from the one simulated. In particular, this
was satisfied with a =0 . 5 ,T =2a n dMinSegLen =
900 for MAD, and default values for BAFsegmentation.
The comparison was assessed using the sensitivity of
each method by measuring the proportion of identified
segments covering at least 50% of the simulated
segment.
Overall MAD showed a better performance when
compared to BAFsegmentation as can be seen in Figure
5. BAFsegmentation achieved good sensitivity in the
range of mosaic cell proportions > 0.07, and null sensi-
tivity for values < 0.05. On the other hand, despite the
lower sensitivity of MAD in the range (0.07, 0.15), there
is an important amount on sensitivity captured in low
values (0.02, 0.05) and a high sensitivity (0.98) at 0.15.
The overall performance of both methods can be com-
pared from the areas under each curve. In the case of
the MAD curve the estimation of this area, normalized
by the area of the perfect sensitivity curve (y =1 ) ,i s
0.109/0.15 = 0.73; whereas for BAFsegmentation this
area is smaller (0.63). Therefore, under this scenario,
MAD showed better sensitivity over the whole range of
mosaic cell proportions. In addition, the computational
time for analyzing the 58 samples described in previous
sections was 3 min 15 sec when using MAD, while BAF-
segmentation needed 42 min 50 sec.
Conclusions
The accurate and appropriate analysis of SNP array data
of genomic DNA from multiple cells allows for the
identification of genomic changes occurring in mosai-
cism and subsequently for the estimation of the affected
cell proportion. The assessment of this increasingly
recognised type of genetic variation is relevant to define
its impact over human diversity and clinical phenotypes.
In this study, we have implemented the so called MAD
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Page 6 of 11tool to detect mosaic events from SNP arrays using the
BAF value as a powerful parameter to detect the allelic
imbalances that underlie mosaic alterations. Our method
was successful in finding previously defined mosaic
chromosomal alterations, and able to detect additional
events in the same data set [17,18], which suggests a
higher sensitivity for MAD. Remarkably, the tool was
able to find mosaic rearrangements of smaller size (~
500 Kb) and events affecting a lower proportion of cells,
uncalled when using other algorithms.
The easy manipulation of the parameters a and T
offers flexibility to the optimization of MAD for a wide
range of circumstances. In contrast, a greater optimiza-
tion of BAFsegmentation has yet to be developed for
truly assessing the performace of the method, especially
for small and low proportion of cells affected Another
significant advantage of MAD is that the FDR can be
directly handled by performing setting changes in its
parameters. High sensitivity and low FDR are essential
in assessing the prevalence of mosaic events in the avail-
able datasets. We have shown how to estimate the FDR
from the segmentation output and, in our simulation
studies, how close is such estimate is very close to the
expected one. However, it is important to note that FDR
also depends on the window for minimum probe length
(MinSegLen). One possible limitation of our method is
the increase in the number of false positives when redu-
cing the (MinSegLen) for analysing arrays with lower
probe coverage.
An unexpectedly increased number of duplications
with respect to deletions were called by MAD. Most of
these calls were not treated as mosaic because their fea-
tures (size, LRR, Bdev, ...) or their plots did not suggest
mosaic occurrence (see Additional File 4). While the
distinction between constitutional and mosaic events is
quite evident for deletions and UPDs, due to the finding
of complete loss of heterozygosity only in non-mosaic
rearrangements, in the case of copy number gains
(duplications, trisomies) it is not so straightforward
because the presence of heterozygous probes is
expected. Due to the technical limitations in array plat-
forms the change in copy number from 2 to 3 or an
intermediate number could be in the same sensitivity
range thus providing LRR and BAF array values similar
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Figure 4 False discovery rate (FDR) validation. Each figure compares the simulated FDR vs. the estimated FDR using the approach given in
the Methods Section for different scenarios. The percentage of mosaic cells in the altered region as well as the quality of the data were
changed.
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Page 7 of 11for both normal gain dosage changes (2 to 3 i.e.) and
mosaic changes occurring in a subset of cells. A com-
parison between MAD analysis and CNV calling process
using PennCNV and filtering procedures revealed that
30 MAD duplications were absent in CNV dataset when
a statistic filter was applied [23,24]. The 98 duplications
showing any overlap in both datasets were 59% identical
on average (range: 3% - 100%) (see Additional File 4).
These results may suggest on one hand that MAD soft-
ware seems to be more effective in calling duplications
than typical CNV calling procedures and, in the other
hand, that some duplication calls observed using MAD
may be non mosaic alterations.
Reanalysis of the previously assessed SNP array data in
[17] demonstrates that there are hidden genomic mosaic
events that cannot be detected by using ad-hoc routines.
The fact that such genomic allelic imbalances can be
smaller and present in a lower proportion of cells,
emphasizes the need of improving and using more
powerful analytical methods. However, an open question
regarding the detection limit remains partially dependent
on the array resolution given that no gold standard exists
to define the false negative rate for most rearrangements
(other than FISH for large segmental or complete aneu-
plodies). While we have shown that MAD can success-
fully detect small and very low mosaicism degree events
and that the prevalence of mosaicism can still be higher,
further improvements are needed in the analysis and
experimental techniques. Mosaicism is an unexpected
source of genetic variation that is still underexplored.
The study of existing and future SNP array datasets, as
well as the application of similar algorithms for allelic
imbalance detection to next-generation sequencing data,
will provide new clues about the impact of such genetic
variation over phenotypic differences in the common
population as well as its influence on disease.
Methods
Analysis methods
Data
The simulated dataset was generated by varying i) the
percentage of cells affected by a deletion type CNV
(varying shift in B allele frequency to be 10% or 20%); ii)
the length of the rearrangement, from large (half chro-
mosome) to small (5% of the chromosome); and iii) the
quality of the hybridization BAF signal data, that were
defined as good (Additional File 1 - Figure S2) or noisy
experiments (Additional File 1 - Figure S3).
The Illumina data set from HapMap individuals com-
prised 120 individuals and 5 replicates and were
retrieved from http://www.illumina.com/. The data
includes 60 CEPH (CEU) and 60 Yoruban (YRI) unre-
lated samples. The Illumina 1M HumanHap SNP array
integrates about 1.0 million probes. Data were normal-
ized by using Illumina BeadStudio software.
A subset of Illumina 1M HumanHap SNP array data
obtanined from 58 individuals who participated in the
Spanish Bladder Cancer study [25] kindly provided by
the NCI Core Genotyping Facility was also analysed.
These data have been already analyzed for mosaic events
using different ad-hoc tools and manual curation [17].
All reported mosaic rearrangements were validated by
additional molecular techniques such as multiplex liga-
tion probe-dependent amplification (MLPA) and micro-
satellite marker analysis and/or FISH [17].
Algorithm
Allelic genomic imbalances (different proportions of the
two homologous chromosome regions) can be detected
from the BAF signal data (Figure 1). The transformed b-
deviation value was calculated for each probe to detect
genomic imbalances. The b-deviation of a probe, bdev,i s
defined as the deviation from the expected BAF given
the genotype,
bdev =

min(BAF, 1−BAF)for homozygotes
abs(BAF−0.5) for heterozygotes (1)
Genomic imbalanced regions are captured by selecting
SNPs with bdev different from 0. This is a segmentation
problem that can be tackled with methods already avail-
able, most of which assume normality in the signal.
Thus, the probit transformation, F
-1 , was used
 −1(bdev)=

0, bdev =0 √
2erf
−1(2bdev − 1), bdev ∈ (0,1)
(2)
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Figure 5 Sensitivity as a function of mosaic cell proportion.
Low proportion of cells affected with the abnormality reduces the
sensitivity to identify a 1 kB mosaic alteration, in a 20 kB region of
200 simulated individuals. Overall MAD showed a better
performance when compared to BAFsegmentation.
González et al. BMC Bioinformatics 2011, 12:166
http://www.biomedcentral.com/1471-2105/12/166
Page 8 of 11where erf denotes the error function (Figure 1C).
Segmentation is then performed on regions with F
-1 ≠
0 using GADA which detects altered segments in two
steps. The first step is a Sparse Bayesian Learning pro-
cess (SBL) that generates a list of candidate break-
points and segment means while trying to strike an
optimal balance between model fit and model sparse-
ness (the number of breakpoints). The SBL step is dri-
ven by two prior parameters a and b and they are
directly controlled by the user. Typically b is set to
zero as an uninformative prior, so sparseness is solely
controlled by a, taking values between 0.2 and 0.8. By
increasing a the algorithm has higher sensitivity but
also higher FDR, which can be further adjusted in the
second step. The significance of each called breakpoint
segment is assessed with a t-statistic computed with
the parameter estimatation provided by the SBL step.
This statistic is a function of the segment mean and
variance. The second step is then a backward elimina-
tion (BE) process which removes breakpoints with a
level of significance (t statistic) lower than the user-
defined threshold, [21] showed that, under the null
hypothesis, if a segment is copy normal, the t-statistic
distribution is normal across the segments. The rank-
ing of breakpoints with the adjustment of T is
obtained with very low computational cost and can be
used to control the FDR.
After calling segments by assessing BAF values the
average LRR is used to carry out a preliminary classifica-
tion of the called segment into different types of mosaic
rearrangements: UPD was considered for LRR Î {-0.10,
0.10}, a deletion when LRR < -.10, a duplication for LRR
> 0.10 and a Trisomy if a deletion was observed in more
than 95% of the chromosome. These values should not
be absolute but relative to the average LRR of the entire
diploid genome (exluding X and Y chromosomes) and
the rest of the chromosome data.
False Discovery Rate estimation
Recommendations on how to choose T and a para-
meters to control both sensitivity and FDR, based on
simulations and specific data (i.e., Affymetrix 500K, Illu-
mina 550) have been given elsewhere [21]. Here, we
propose a general method to control the FDR indepen-
dent of reference arrays and resolution, derived from a
previously reported one [26].
The hypothesis of no alteration for the i-th segment,
Si, can be stated as
Hi
0 : μi =0 , (3)
where μi denotes the mean of F
-1(bdev )a c r o s sa l lni
probes in Si. For each Si , GADA provides a statistic, ti .
Under the null hyphotesis the distribution of ti is N (0,
1) for a large number of probes, whereas for a small
number of probes it follows a t-Student distribution, tν ,
with ν = ni - 1 degrees of freedom. If pk = P (t >| ti|)
and ti are independent from each other, for a given T ,
a conservative estimator of the genome-wide FDR is
F ˆ DR(T)=
NP(tν > T)

k nkIpk ≤ P(tν > T)
, (4)
where N is the total number of probes in the array.
Software
MAD is included in the R-GADA software [27] that is
available at
http://www.creal.cat/jrgonzalez/software.htm. A
detailed tutorial describing how to analyze SNP array
data is available in the Additional File 5.
Experimental validation
DNA samples were obtained from 6 out of 7 individuals
showing mosaic abnormalities in Table 2. Validation of
algorithm findings was carried out by using multiplex
ligation-dependent probe amplification (MLPA) techni-
que [28]. The MLPA reactions were carried out essen-
tially as described previously [28] with slight
modifications [29]. We used both visual examination of
the electropherograms and the relative peak height
(RPH) method recommended by MRC-Holland for data
analysis [30]. The complete list and details of used
MLPA probes is shown in Additional File 6.
Additional material
Additional file 1: File including figures for examples of simulated
data sets, some simulation results and new mosaic abnormalities
detected using MAD in SNP arrary data previously analyzed with
ad-hoc tools (Rodriguez-Santiago et al., 2010).
Additional file 2: Recommended parameters for a preliminary scan
using different Illumina platforms.
Additional file 3: Comparison between MAD findings and
chromosomal abnormalities previously described in HapMap
individuals also analysed in Redon et al., Nature, 2006.
Additional file 4: Additional analysis using PennCNV to discard
mosaic detected with MAD with consitutional duplications.
Additional file 5: User’s guide of an R package that implements
MAD algorithm including some real data examples.
Additional file 6: List and details of used MLPA probes for
validating new mosaic rearrangements.
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